Chromafenozide

CAS No. 143807-66-3

Chromafenozide( ANS118 )

Catalog No. M23604 CAS No. 143807-66-3

Chromafenozide (ANS118) is a lepidopteran insecticide with the effect of controlling various lepidopteran pests.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 140 In Stock
5MG 120 In Stock
10MG 172 In Stock
25MG 297 In Stock
50MG 423 In Stock
100MG 594 In Stock
200MG 820 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Chromafenozide
  • Note
    Research use only, not for human use.
  • Brief Description
    Chromafenozide (ANS118) is a lepidopteran insecticide with the effect of controlling various lepidopteran pests.
  • Description
    Chromafenozide (ANS118) is a lepidopteran insecticide with the effect of controlling various lepidopteran pests.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ANS118
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    143807-66-3
  • Formula Weight
    394.51
  • Molecular Formula
    C24H30N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:250 mg/mL (633.70 mM; Need ultrasonic)
  • SMILES
    O=C(C1=CC=C2C(CCCO2)=C1C)NN(C(C3=CC(C)=CC(C)=C3)=O)C(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Abdelraheem E , Arief M , Mohammad S G , et al. Safety assessment of chromafenozide residue level with decline study on tomato in Egypt[J]. Environmental Monitoring & Assessment, 2017, 189(4):180.
molnova catalog
related products
  • Kinase Domain of Pyr...

    Kinase Domain of Pyruvate Kinase, porcine liver

  • Simlukafusp alfa

    Simlukafusp alfa (FAP-IL2v) is a tumor-targeting immune cytokine, a human IgG1 antibody, with antitumor activity and immunostimulatory properties that potentiate in vitro and in vivo activity of therapeutic antibodies mediating antibody-dependent or T-cell-independent cytotoxicity (TDCC) and programmed death ligand 1 (PD-L1) checkpoint inhibition.

  • [Met5, Lys6] a-Neo-E...

    [Met5, Lys6] a-Neo-Endorphin (1-6)